All Stories

  1. Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis

    Article • Journal of Clinical and Translational Hepatology, January 2024, Xia & He Publishing

    Dr Antonio Picardi

  2. Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management

    Article • Chemotherapy, December 2021, Karger Publishers

    Dr Antonio Picardi

  3. Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank

    Article • International Journal of Obesity, November 2021, Springer Science + Business Media

    Dr Antonio Picardi

  4. Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank

    Article • JHEP Reports, June 2021, Elsevier

    Dr Antonio Picardi

  5. Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis

    Article • Current Drug Metabolism, December 2020, Bentham Science Publishers

    Dr Antonio Picardi

  6. Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people

    Article • Digestive and Liver Disease, September 2019, Elsevier

    Dr Antonio Picardi

  7. Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients

    Article • European Journal of Internal Medicine, July 2019, Elsevier

    Dr Antonio Picardi

  8. Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis

    Article • Journal of Viral Hepatitis, September 2018, Wiley

    Dr Antonio Picardi

  9. Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study

    Article • Canadian Journal of Gastroenterology and Hepatology, January 2018, Hindawi Publishing Corporation

    Dr Antonio Picardi

  10. Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology

    Article • PLOS One, May 2016, PLOS

    Dr Antonio Picardi

  11. The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients

    Article • Scandinavian Journal of Gastroenterology, May 2016, Taylor & Francis

    Dr Antonio Picardi

  12. Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study

    Article • Scientific Reports, May 2016, Nature

    Dr Antonio Picardi

  13. Lysosomal acid lipase activity is reduced in patients with cirrhosis and associated with surrogate indices of portal hypertension

    Article • Digestive and Liver Disease, February 2016, Elsevier

    Dr Antonio Picardi

  14. Proton pump inhibitor prescription abuse and sepsis in cirrhosis

    Article • World Journal of Gastrointestinal Pharmacology and Therapeutics, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Antonio Picardi

  15. The Liver as Another Possible Target Organ for Bacillus cereus Infection

    Article • Case Reports in Infectious Diseases, January 2016, Wiley

    Dr Antonio Picardi

  16. Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy

    Article • Metabolic Brain Disease, August 2015, Springer Science + Business Media

    Dr Antonio Picardi

  17. Portal inflammation during NAFLD is frequent and associated with the early phases of putative hepatic progenitor cell activation

    Article • Journal of Clinical Pathology, June 2015, BMJ

    Dr Antonio Picardi

  18. Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience

    Article • Expert Review of Anticancer Therapy, June 2015, Informa Healthcare

    Dr Antonio Picardi

  19. Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens

    Article • World Journal of Gastroenterology, January 2015, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Antonio Picardi

  20. Determinants of alanine aminotransferase levels in a large population from Southern Italy: Relationship between alanine aminotransferase and age

    Article • Digestive and Liver Disease, October 2014, Elsevier

    Professor Emiliano Schena, Dr Antonio Picardi

  21. Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency

    Article • Digestive and Liver Disease, September 2014, Elsevier

    Dr Antonio Picardi, Professor Sandro Vento

  22. 1539PLIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE

    Article • Annals of Oncology, September 2014, Oxford University Press (OUP)

    Dr Antonio Picardi

  23. Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship

    Article • Journal of Viral Hepatitis, June 2014, Wiley

    Dr Antonio Picardi

  24. Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination

    Article • BMC Gastroenterology, May 2014, Springer Science + Business Media

    Dr Antonio Picardi

  25. Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD

    Article • Liver International, April 2014, Wiley

    Dr Antonio Picardi

  26. Letter to the Editor Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD)

    Article • Archives of Medical Science, January 2014, Termedia Sp. z.o.o.

    Dr Antonio Picardi

  27. Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Antonio Picardi

  28. Prophylaxis of venous thromboembolism in elderly patients with multimorbidity

    Article • Internal and Emergency Medicine, May 2013, Springer Science + Business Media

    Dr Antonio Picardi

  29. Comparison of Disease Clusters in Two Elderly Populations Hospitalized in 2008 and 2010

    Article • Gerontology, January 2013, Karger Publishers

    Dr Antonio Picardi

  30. Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography

    Article • Archives of Medical Science, January 2013, Termedia Sp. z.o.o.

    Dr Antonio Picardi

  31. Risk factors for hospital readmission of elderly patients

    Article • European Journal of Internal Medicine, January 2013, Elsevier

    Dr Antonio Picardi

  32. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus

    Article • Hepatology, December 2012, Wiley

    Dr Antonio Picardi

  33. HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

    Article • BMC Gastroenterology, November 2012, Springer Science + Business Media

    Dr Antonio Picardi

  34. Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma

    Article • Expert Review of Anticancer Therapy, October 2012, Taylor & Francis

    Dr Antonio Picardi

  35. Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver

    Article • Digestive and Liver Disease, August 2012, Elsevier

    Dr Antonio Picardi

  36. Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients

    Article • Journal of Viral Hepatitis, April 2012, Wiley

    Dr Antonio Picardi

  37. Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease

    Article • Modern Pathology, December 2011, Springer Science + Business Media

    Dr Antonio Picardi

  38. Deep Vein Thrombosis, Inferior Vena Cava Interruption and Multiple Thrombophilic Gene Mutations

    Article • The American Journal of the Medical Sciences, July 2011, Elsevier

    Dr Antonio Picardi

  39. Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study

    Article • Journal of Viral Hepatitis, April 2011, Wiley

    Dr Antonio Picardi

  40. Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly

    Article • European Journal of Internal Medicine, April 2011, Elsevier

    Dr Antonio Picardi

  41. The role ofS-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen

    Article • Expert Opinion on Drug Safety, March 2011, Informa Healthcare

    Dr Antonio Picardi

  42. Gas exchanges and pulmonary vascular abnormalities at different stages of chronic liver disease

    Article • Liver International, February 2011, Wiley

    Dr Antonio Picardi

  43. Angiogenic Cytokines in Patients Undergoing Antiviral Treatment for Chronic Hepatitis C Virus Infection

    Article • Journal of Interferon & Cytokine Research, February 2011, Mary Ann Liebert Inc

    Dr Antonio Picardi

  44. The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen

    Article • Supportive Care in Cancer, January 2011, Springer Science + Business Media

    Dr Antonio Picardi

  45. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study

    Article • European Journal of Clinical Pharmacology, January 2011, Springer Science + Business Media

    Dr Antonio Picardi

  46. Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma

    Article • World Journal of Hepatology, January 2011, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Antonio Picardi

  47. Non-cirrhotic portal hypertension with large regenerative nodules: A diagnostic challenge

    Article • World Journal of Gastroenterology, January 2011, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Antonio Picardi

  48. Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards

    Article • European Journal of Internal Medicine, December 2010, Elsevier

    Dr Antonio Picardi

  49. In-hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study

    Article • International Journal of Geriatric Psychiatry, November 2010, Wiley

    Dr Antonio Picardi

  50. Gene therapy and enhancement for diabetes (and other diseases): the multiplicity of considerations

    Article • Diabetes/Metabolism Research and Reviews, September 2010, Wiley

    Dr Antonio Picardi

  51. Blood glucose monitoring in the normal population: the PREDICA study

    Article • Acta Diabetologica, August 2010, Springer Science + Business Media

    Dr Antonio Picardi

  52. In-Hospital Death and Adverse Clinical Events in Elderly Patients According to Disease Clustering: The REPOSI Study

    Article • Rejuvenation Research, August 2010, Mary Ann Liebert Inc

    Dr Antonio Picardi

  53. Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial

    Article • BMC Gastroenterology, February 2010, Springer Science + Business Media

    Dr Antonio Picardi

  54. Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon α-2a and ribavirin: a multicentric study

    Article • Liver International, November 2009, Wiley

    Dr Antonio Picardi

  55. Interaction of alcohol intake and cofactors on the risk of cirrhosis

    Article • Liver International, October 2009, Wiley

    Dr Antonio Picardi

  56. A mocking finding: portal cavernoma mimicking neoplastic mass: first sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation

    Article • European Journal of Gastroenterology & Hepatology, February 2009, Wolters Kluwer Health

    Dr Antonio Picardi

  57. Association Between Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: A First Message Should Pass

    Article • The American Journal of Gastroenterology, December 2008, Wolters Kluwer Health

    Dr Antonio Picardi

  58. Menarche in type 1 diabetes is still delayed despite good metabolic control

    Article • Fertility and Sterility, November 2008, Elsevier

    Dr Antonio Picardi

  59. Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients

    Article • Medical Microbiology and Immunology, August 2008, Springer Science + Business Media

    Dr Antonio Picardi

  60. Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature

    Article • Journal of Experimental & Clinical Cancer Research, August 2008, Springer Science + Business Media

    Dr Antonio Picardi

  61. Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertension

    Article • Diabetes/Metabolism Research and Reviews, July 2008, Wiley

    Dr Yeganeh Manon Khazrai, Dr Antonio Picardi

  62. The PTPN22 1858T Gene Variant in Type 1 Diabetes Is Associated With Reduced Residual  -Cell Function and Worse Metabolic Control

    Article • Diabetes Care, February 2008, American Diabetes Association

    Dr Antonio Picardi

  63. 826 ANTIVIRAL TREATMENT OF HCV CARRIERS WITH NORMAL ALT

    Article • Journal of Hepatology, January 2008, Elsevier

    Dr Antonio Picardi

  64. Peripheral Graft Infection due to Staphylococcus aureus without Abnormal Findings by 99mTc-HMPAO-Labeled-Leukocyte Scan

    Article • Internal Medicine, January 2008, Japanese Society of Internal Medicine

    Dr Antonio Picardi

  65. Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model

    Article • BMC Gastroenterology, December 2007, Springer Science + Business Media

    Dr Antonio Picardi

  66. Lower schooling, higher hepatitis C virus prevalence in Italy: An association dependent on age

    Article • Journal of Clinical Virology, October 2007, Elsevier

    Dr Antonio Picardi

  67. Portal Diameter in the Diagnosis of Esophageal Varices in 266 Cirrhotic Patients: Which Role?

    Article • Ultrasound in Medicine & Biology, April 2007, Elsevier

    Dr Antonio Picardi

  68. Raised C-reactive protein levels in patients with recent onset type 1 diabetes

    Article • Diabetes/Metabolism Research and Reviews, January 2007, Wiley

    Dr Antonio Picardi

  69. Chemotherapy-Induced Steatohepatitis in Colorectal Cancer Patients

    Article • Journal of Clinical Oncology, November 2006, American Society of Clinical Oncology (ASCO)

    Dr Antonio Picardi

  70. Glucose Abnormalities in Patients With Hepatitis C Virus Infection: Epidemiology and Pathogenesis: Response to Lecube et al.

    Article • Diabetes Care, October 2006, American Diabetes Association

    Dr Antonio Picardi

  71. Metabolic Factors Affecting Residual Beta Cell Function Assessed by C-Peptide Secretion in Patients with Newly Diagnosed Type 1 Diabetes

    Article • Hormone and Metabolic Research, October 2006, Thieme Publishing Group

    Dr Antonio Picardi

  72. Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study)

    Article • Pediatric Diabetes, August 2006, Wiley

    Dr Antonio Picardi

  73. Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease

    Article • Histopathology, June 2006, Wiley

    Dr Antonio Picardi

  74. Left common and right internal carotid artery occlusion - color-coded duplex sonography and magnetic resonance angiography findings

    Article • European Journal of Neurology, April 2006, Wiley

    Dr Antonio Picardi

  75. Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon

    Article • Clinical Immunology, February 2006, Elsevier

    Dr Antonio Picardi

  76. Associations between the IGF system and inflammatory markers in inflammatory bowel disease: authors' reply

    Article • Alimentary Pharmacology & Therapeutics, February 2006, Wiley

    Dr Antonio Picardi

  77. Diabetes in chronic liver disease: from old concepts to new evidence

    Article • Diabetes/Metabolism Research and Reviews, January 2006, Wiley

    Dr Antonio Picardi

  78. Vitamin D T1D

    Article • Hormone and Metabolic Research, November 2005, Thieme Publishing Group

    Dr Yeganeh Manon Khazrai, Dr Antonio Picardi

  79. Retroperitoneal Fibrosis and Ankylosing Spondylitis: Which Links?

    Article • Seminars in Arthritis and Rheumatism, August 2005, Elsevier

    Dr Antonio Picardi

  80. Isolated Hepatocytes versus Hepatocyte Spheroids: In Vitro Culture of Rat Hepatocytes

    Article • Cell Transplantation, July 2005, SAGE Publications

    Dr Antonio Picardi

  81. Infliximab reverses growth hormone resistance associated with inflammatory bowel disease

    Article • Alimentary Pharmacology & Therapeutics, May 2005, Wiley

    Dr Antonio Picardi

  82. Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs

    Article • International Immunopharmacology, March 2005, Elsevier

    Dr Antonio Picardi

  83. Iloprost: an adjunctive approach to chronic viral hepatitis treatment

    Article • Medical Hypotheses, January 2005, Elsevier

    Dr Antonio Picardi

  84. Treatment of Cryptosporidiosis in Immunocompromised Hosts

    Article • Chemotherapy, January 2005, Karger Publishers

    Dr Antonio Picardi

  85. Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype

    Article • Diabetes/Metabolism Research and Reviews, January 2005, Wiley

    Dr Antonio Picardi

  86. Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates

    Article • Clinical Rheumatology, December 2004, Springer Science + Business Media

    Dr Antonio Picardi

  87. The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection

    Article • Current Pharmaceutical Design, July 2004, Bentham Science Publishers

    Dr Antonio Picardi

  88. Improved Hepatic Perfusion After Iloprost Infusion in Patients with HCV Chronic Infection: A Pilot Study with Possible Therapeutic Implications

    Article • Journal of Interferon & Cytokine Research, May 2004, Mary Ann Liebert Inc

    Dr Antonio Picardi

  89. Guest Editorial

    Article • Diabetic Medicine, November 2003, Wiley

    Dr Antonio Picardi

  90. The antineoplastic role of bisphosphonates: from basic research to clinical evidence

    Article • Annals of Oncology, October 2003, Oxford University Press (OUP)

    Dr Antonio Picardi

  91. TNF- α and Growth Hormone Resistance in Patients with Chronic Liver Disease

    Article • Journal of Interferon & Cytokine Research, May 2003, Mary Ann Liebert Inc

    Dr Antonio Picardi

  92. Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease

    Article • Journal of Hepatology, April 2003, Elsevier

    Dr Antonio Picardi

  93. GH-resistance in different stages of chronic liver disease

    Article • Journal of Hepatology, April 2003, Elsevier

    Dr Antonio Picardi

  94. Hemodynamic effects of a prostacyclin analog (iloprost) on portal flow velocity and volume and visceral artery circulation in patients with lower limb arteriopathy

    Article • Ultrasound in Medicine & Biology, February 2003, Elsevier

    Dr Antonio Picardi

  95. Severe Liver Dysfunction After Raltitrexed Administration in an HCV-Positive Colorectal Cancer Patient

    Article • Cancer Investigation, January 2003, Taylor & Francis

    Dr Antonio Picardi

  96. Viral cirrhosis with chronic right heart failure and cardiac liver sclerosis: a hypothesis on the differentiation between the two diseases through pulsed Doppler sonography examination

    Article • Medical Hypotheses, November 2002, Elsevier

    Dr Antonio Picardi

  97. Development of a New Bioartificial Liver Using a Porcine Autologous Biomatrix as Hepatocyte Support

    Article • ASAIO Journal, November 2002, Wolters Kluwer Health

    Dr Antonio Picardi

  98. Case Report: Liver Cirrhosis After Prolonged Therapy with IFN- α plus Interleukin-2 in a Metastatic Renal Cancer Long-Term Survivor

    Article • Journal of Interferon & Cytokine Research, June 2002, Mary Ann Liebert Inc

    Dr Antonio Picardi

  99. Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment

    Article • Journal of Hepatology, January 1998, Elsevier

    Dr Antonio Picardi, MARIA GARCIA FERNANDEZ

  100. Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis

    Article • Journal of Hepatology, January 1997, Elsevier

    Dr Antonio Picardi

  101. Percutaneous transhepatic stenting by wallstents of portal vein and bile duct stenoses caused by immunoblastic sarcoma in a liver transplantation

    Article • Cardiovascular Radiology, July 1994, Springer Science + Business Media

    Dr Antonio Picardi

  102. Reversal of basal ganglia hyperintensity on T1-weighted images on MRI after successful orthotopic liver transplantation (OLT)

    Article • Hepatology, September 1993, Elsevier

    Dr Antonio Picardi

  103. Effectiveness of Aprotinin in Orthotopic Liver Transplantation

    Article • Seminars in Thrombosis and Hemostasis, July 1993, Thieme Publishing Group

    Dr Antonio Picardi

  104. Indirect pathway of liver glycogen synthesis in humans is predominant and independent of beta-adrenergic mechanisms

    Article • Clinical Physiology and Functional Imaging, November 1992, Wiley

    Dr Antonio Picardi

  105. Intravenous infusion of diarginylinsulin, an insulin analogue: Effects on glucose turnover and lipid levels in insulin-treated type II diabetic patients

    Article • Metabolism, May 1992, Elsevier

    Dr Antonio Picardi